Alzheimer's disease trials recruiting in Florida

All Alzheimer's disease trials nationally

Cities in Florida

Recruiting trials in Florida

• A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
  NCT07033494 · Phase: Phase 2 · Ages: 50 Years to 85 Years · Sex: All (male and female) · Florida: Atlantis, Fort Myers, Maitland, Melbourne
• A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
  NCT07170150 · Phase: Phase 3 · Ages: 50 Years to 90 Years · Sex: All (male and female) · Florida: Atlantis, Clermont, Miami, Orlando
• A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
  NCT07094516 · Phase: Phase 2 · Ages: 50 Years to 85 Years · Sex: All (male and female) · Florida: Atlantis, Aventura, Maitland, Ocala
• A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
  NCT06297590 · Phase: Phase 1 · Ages: 50 Years to 85 Years · Sex: All (male and female) · Florida: Maitland, The Villages
• A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
  NCT07011745 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · Florida: Aventura, Bonita Springs, Bradenton, Doral
• A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
  NCT07011732 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · Florida: Maitland, Merritt Island, Miami, Ocala
• A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
  NCT07602582 · Phase: Phase 3 · Ages: 55 Years and older · Sex: All (male and female) · Florida: Aventura, Bradenton, Greenacres City, Jacksonville
• A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
  NCT07589595 · Phase: Phase 2 · Ages: 55 Years to 85 Years · Sex: All (male and female) · Florida: Atlantis, Aventura, Delray Beach, Fort Myers
• A Study of LY3439539 in Participants With Alzheimer's Disease
  NCT07598370 · Phase: Phase 1 · Ages: 50 Years to 85 Years · Sex: All (male and female) · Florida: Orlando
• A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)
  NCT06657768 · Phase: Phase 1 · Ages: 45 Years to 85 Years · Sex: All (male and female) · Florida: Lady Lake, Maitland, Naples, Port Orange
• A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
  NCT07717411 · Phase: Phase 3 · Ages: 55 Years to 80 Years · Sex: All (male and female) · Florida: Maitland
• A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
  NCT07169578 · Phase: Phase 3 · Ages: 50 Years to 90 Years · Sex: All (male and female) · Florida: Lady Lake, Maitland, Ocala, Tampa
• A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
  NCT07633470 · Phase: Phase 4 · Ages: 50 Years and older · Sex: All (male and female) · Florida: Aventura, Hialeah, Melbourne, Miami
• A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
  NCT05511363 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · Florida: Boca Raton, Bonita Springs, Bradenton, Clermont
• A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
  NCT06126224 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · Florida: Apopka, Clermont, Cutler Bay, Delray Beach
• A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
  NCT05462106 · Phase: Phase 1, Phase 2 · Ages: 35 Years to 85 Years · Sex: All (male and female) · Florida: Lady Lake, Orlando, The Villages
• A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia
  NCT06651567 · Phase: Phase 2 · Ages: 55 Years and older · Sex: All (male and female) · Florida: Boca Raton, Bonita Springs, Brandon, Delray Beach
• A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
  NCT06540833 · Phase: Phase 2 · Ages: 55 Years and older · Sex: All (male and female) · Florida: Bonita Springs, Brandon, Coral Springs, Delray Beach
• A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
  NCT06887192 · Phase: Phase 2 · Ages: 55 Years to 90 Years · Sex: All (male and female) · Florida: Boca Raton, Deerfield Beach, Doral, Homestead
• A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
  NCT07599670 · Phase: Phase 1, Phase 2 · Ages: 50 Years to 90 Years · Sex: All (male and female) · Florida: Bradenton, Clermont, Lady Lake, Stuart
• A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
  NCT06585787 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · Florida: Atlantis, Bonita Springs, Cutler Bay, Daytona Beach
• A Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down Syndrome-Associated Alzheimer's Disease (DS-AD)
  NCT07636811 · Phase: Phase 2 · Ages: 40 Years to 55 Years · Sex: All (male and female) · Florida: Maitland, Naples
• A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
  NCT06947941 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · Florida: Naples
• A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
  NCT06976216 · Phase: Phase 3 · Ages: 60 Years to 85 Years · Sex: All (male and female) · Florida: Atlantis, Aventura, Merritt Island, Ocala
• A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
  NCT06976203 · Phase: Phase 3 · Ages: 60 Years to 85 Years · Sex: All (male and female) · Florida: Fort Myers, Hallandale, Jacksonville, Lady Lake
• A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
  NCT06937229 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · Florida: Bonita Springs, Miami, Orlando, Port Orange
• A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
  NCT07688213 · Phase: Phase 2 · Ages: 55 Years to 85 Years · Sex: All (male and female) · Florida: The Villages
• ACP-204 in Adults With Alzheimer's Disease Psychosis
  NCT06159673 · Phase: Phase 2, Phase 3 · Ages: 55 Years to 95 Years · Sex: All (male and female) · Florida: Aventura, Daytona Beach, Doral, Hialeah
• AV-1980R (Tau Vaccine) in Preclinical Alzheimer's Disease (TAURUS-1980)
  NCT07158905 · Phase: Phase 1 · Ages: 65 Years to 80 Years · Sex: All (male and female) · Florida: Boca Raton, Miami Lakes, Stuart, Tampa
• Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
  NCT06563895 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Florida: Jacksonville, Miami, Weston
• Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy
  NCT03657745 · Phase: Not specified · Ages: 50 Years and older · Sex: All (male and female) · Florida: Miami
• An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheimer's Disease
  NCT07764146 · Phase: Phase 1 · Ages: 30 Years to 80 Years · Sex: All (male and female) · Florida: Maitland
• Anxiety Sensitivity Treatment to Reduce Anxiety in Alzheimer's
  NCT05748613 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years and older · Sex: All (male and female) · Florida: Tallahassee
• Brain NAD in Alzheimer's Disease
  NCT07127510 · Phase: Not specified · Ages: 65 Years to 80 Years · Sex: All (male and female) · Florida: Boca Raton
• Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease
  NCT06189963 · Phase: Phase 1, Phase 2 · Ages: 40 Years to 85 Years · Sex: All (male and female) · Florida: Maitland, Orlando
• Clinical Trial on Agitation in Alzheimer's Dementia
  NCT05543681 · Phase: Phase 2 · Ages: 60 Years and older · Sex: All (male and female) · Florida: Maitland, Melbourne, Miami, Port Charlotte
• Combating Alzheimer's Through Sleep and Exercise
  NCT04855630 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 80 Years · Sex: All (male and female) · Florida: Miami
• Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
  NCT06584357 · Phase: Not specified · Ages: 60 Years to 90 Years · Sex: All (male and female) · Florida: Atlantis, Aventura, Clermont, Delray Beach
• Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type
  NCT06052254 · Phase: Phase 2 · Ages: No age limits stated · Sex: All (male and female) · Florida: Daytona Beach, Delray Beach, Miami, St. Petersburg
• Dominantly Inherited Alzheimer Network (DIAN)
  NCT00869817 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Florida: Jacksonville
• Dynamic Light Scattering Ocular Measurement in the Detection of Dementia
  NCT06613971 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Florida: Coconut Creek
• ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease
  NCT03671889 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 85 Years · Sex: All (male and female) · Florida: Delray Beach, Fort Lauderdale, Gainesville, Miami
• Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease.
  NCT07512362 · Phase: Phase 2 · Ages: 55 Years to 90 Years · Sex: All (male and female) · Florida: Miami
• Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease.
  NCT06781333 · Phase: Phase 2 · Ages: 55 Years to 90 Years · Sex: All (male and female) · Florida: Miami
• Late Onset Alzheimer's Disease
  NCT05010603 · Phase: Not specified · Ages: 55 Years and older · Sex: All (male and female) · Florida: Miami
• Longitudinal Cognitive Assessment by BoCA
  NCT04114994 · Phase: Not specified · Ages: 50 Years and older · Sex: All (male and female) · Florida: Miami
• Low-Dose Radiotherapy for Alzheimer's Disease
  NCT07693140 · Phase: Phase 1, Phase 2 · Ages: 50 Years and older · Sex: All (male and female) · Florida: Winter Park
• Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
  NCT05397639 · Phase: Phase 3 · Ages: 50 Years to 90 Years · Sex: All (male and female) · Florida: Miami, Orlando, Pompano Beach
• Microbiome in Aging of Gut and Brain
  NCT07799402 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Florida: Tampa
• Neurologic Stem Cell Treatment Study
  NCT02795052 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Florida: Coral Springs
• Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
  NCT05980949 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · Florida: Atlantis, Boca Raton, Bonita Springs, Bradenton
• Open-label Extension Study in Participants With Early Alzheimer's Disease
  NCT07105709 · Phase: Phase 2 · Ages: 50 Years to 85 Years · Sex: All (male and female) · Florida: Maitland, Miami, Stuart
• Palliative Care Education in Assisted Living for Dementia Care Providers (PCEAL-DCP)
  NCT06722352 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years and older · Sex: All (male and female) · Florida: Tampa
• Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among Blacks
  NCT06089161 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years to 85 Years · Sex: All (male and female) · Florida: Miami
• Pulsed Electromagnetic Field Treatment With Dementia Patients
  NCT06862557 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 100 Years · Sex: All (male and female) · Florida: Boca Raton
• Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease
  NCT07178210 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years and older · Sex: All (male and female) · Florida: Jacksonville
• Safety, PK and Biodistribution of 18F-OP-801 in Patients With ALS, AD, MS, PD and Healthy Volunteers
  NCT05395624 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Florida: Jacksonville
• Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
  NCT07177352 · Phase: Phase 3 · Ages: 50 Years to 90 Years · Sex: All (male and female) · Florida: Atlantis, Clermont, Lady Lake, Maitland
• Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease
  NCT03821857 · Phase: Phase 4 · Ages: 60 Years and older · Sex: Female · Florida: Jacksonville
• Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
  NCT06847321 · Phase: Phase 2 · Ages: 55 Years to 80 Years · Sex: All (male and female) · Florida: Atlantis, Delray Beach, Fort Myers, Orlando
• Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
  NCT06808984 · Phase: Phase 2 · Ages: 55 Years to 90 Years · Sex: All (male and female) · Florida: Daytona Beach, Maitland, Miami, Tampa
• University of Central Florida CereBank
  NCT06876857 · Phase: Not specified · Ages: 18 Years and older · Sex: Female · Florida: Orlando
• [18F]PI-2620 Phase 3 Histopathological Study
  NCT05641688 · Phase: Phase 3 · Ages: 50 Years and older · Sex: All (male and female) · Florida: Hialeah, Jacksonville, Lady Lake, Maitland